InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Saturday, 09/16/2017 7:51:28 AM

Saturday, September 16, 2017 7:51:28 AM

Post# of 5004

Well looky here, PR about NIH funding for spinal cord injury in the morning, followed by the departure of Dr. Alexey Eliseev, the company's chief business officer. RXII is in total shambles, first the CSO steps away from role then heads to the board of directors, now the CBO steps down. This company is such a disaster for investors to be in. For those reading this please do not invest in this company. If you must be in it you can day trade it maybe, but a long-term investment here means losing 99% of your entire investment. Stay away pls!

http://www.prnewswire.com/news-releases/rxi-pharmaceuticals-announces-the-departure-of-dr-alexey-eliseev-as-chief-business-officer-300520630.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News